SUGI Holdings Revamps Governance Line-up Ahead of May 2026 Shareholders’ Meeting

An announcement from Sugi Holdings Co ( (JP:7649) ) is now available.

SUGI Holdings has announced changes to its management structure, confirming the slate of director candidates to be submitted for approval at its 44th Ordinary General Meeting of Shareholders scheduled for late May 2026. The current leadership team, including Chairman Eiichi Sakakibara and Representative Director and President Katsunori Sugiura, is set to be reappointed, while Shinya Sugiura will continue in an expanded leadership role as Representative Director and Vice President responsible for medical care, prescription dispensing and nursing care, alongside the reappointment of several external directors. The company will also propose the appointment of Masahiro Nakamura, a veteran banker with extensive executive experience at The Bank of Nagoya and multiple outside governance roles, as a new external auditor replacing retiring auditor Kana Yasuda, a move that underscores SUGI Holdings’ focus on strengthening oversight and financial governance as it manages growth in its healthcare-related businesses.

The most recent analyst rating on (JP:7649) stock is a Buy with a Yen4200.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

More about Sugi Holdings Co

SUGI Holdings Co., Ltd. is a Japan-based company listed on the Tokyo Stock Exchange Prime and Nagoya Stock Exchange Premier, operating in the healthcare and retail sector through drugstores and related medical and nursing-care services. The group focuses on prescription dispensing, medical care support, and community-based healthcare offerings, positioning itself as a key player in regional health and wellness services.

YTD Price Performance: 3.77%

Average Trading Volume: 511,232

Technical Sentiment Signal: Buy

Current Market Cap: Yen720.7B

See more data about 7649 stock on TipRanks’ Stock Analysis page.